Skip to Main Content

Paper Details

Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
Front Immunol
11
2021
B, COVID-19, Convalescent plasma, IgA, IgG, IgM, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 RNA, T and B cell lymphopenia, anti-, anti-CD20 monoclonal antibody, anti-SARS-CoV-2 neutralizing antibodies, blood cell, chronic lymphoid leukemia, convalescent plasma, immunocompromised, immunosuppressed, inflammation, patient, patients, pneumonia, rituximab
Author NameAffiliation
Marie M??anLausanne University Hospital and University of Lausanne
Peter VollenweiderLausanne University Hospital and University of Lausanne
Peter VollenweiderLausanne University Hospital and University of Lausanne
  • 1 - 3

Datasets

Release 1.2